Can These Penny Stocks Move Higher Before Thanksgiving?
The main goal for any investor is identifying stocks that show a potential for profits. This can come from blue-chip stocks or even penny stocks. I mention penny stocks because they have the unique capacity to bring extremely nice profits in a very short amount of time. However, the disadvantage of them compared to blue-chip stocks is their uncertainty, riskiness, and speculative nature.
So how can you make such a risky investment work for you? First off, do your research. And I don’t mean look at a couple of articles here and there, I mean dive into financials, investigate the sector’s history, etc. The next thing I would recommend is to paper trade at first in order to develop your trading strategies.
This will help familiarize you with stop-loss orders as well as market trends. To help you get started with your research, here are a few penny stocks to watch that have had recent news catalysts:
Penny Stocks To Watch #1: Cancer Genetics Inc. (CGIX)
Kicking things off this morning is a biotechnology company known as Cancer Genetics Inc. (CGIX Stock Report). Cancer Genetics is a leader in DNA-based cancer diagnostics and it services some of the best medical institutions on Earth.
These services are mainly testing specific biomarkers to provide insights regarding the likelihood of responding to certain treatments. These DNA tests target several forms of cancers including hematological, urogenital, and HPV-associated cancers.
This penny stock is making noise early during November 20th’s trading session. The stock is up 126% and trading with over 10 times its average trading volume. This all comes after Cancer Genetics reported its Q3 financial results and business update. These financials showed a 35% growth in revenues from the previous quarter and that the company was able to deliver on cost reduction initiatives and zeroed in on drug discovery and preclinical services.
Read More
- 4 Penny Stocks To Buy For Under $2.50 Right Now
- Top Penny Stocks to Buy Or Avoid Amid Growing Optimism
- Penny Stocks On Robinhood To Watch This Week
In regards to the company’s financials, John Roberts, CEO of Cancer Genetics, expressed, “Our Discovery Services business is self-sustaining, thereby eliminating any further operating cash burn, and we are now focused on collecting cash that is due to the Company, substantially reducing our accounts payable with our unsecured creditors, focusing on the operational elements of our Discovery Services business, and continuing to explore strategic alternatives, which could include the sale of other assets, a merger or other strategic transactions.”
Penny Stocks To Watch #2: Yield10 Bioscience Inc. (YTEN)
Mixing things up is a company from the agricultural technology industry that goes by the name Yield10 Bioscience Inc. (YTEN Stock Report). Yield10 Bioscience is focused on creating technologies that achieve step-change improvements in crop yield.
The goal of these technologies is to enhance global food security as population growth continues to rise. So far, the company has advanced the yield traits of crops like corn, canola, and soybean.
The company recently announced that it will be finally closing its underwritten public offering. From this public offering, the company gained gross proceeds of $11.5 million from the 12,480,000 Class A Units. Since this penny stock news broke, Yield10’s stock price has risen from $0.1225 to $0.1441, a 17.6% jump on November 20th. Furthermore, the company currently has a volume of 4.7 million shares compared to its average trading volume of 300 thousand.
Penny Stocks To Watch #3: Diffusion Pharmaceuticals Inc. (DFFN)
The next company on this list is another biotechnology company with a different focus. Diffusion Pharmaceuticals Inc. (DFFN Stock Report) is a biopharmaceutical company that is attempting to improve the effectiveness of standard-of-care therapies for life-threatening treatment-resistant solid cancerous tumors.
At the moment, the company currently has 5 treatment plans within its clinical pipeline. The company’s lead product candidate is for the treatment of glioblastoma, a cancer in the glial cells in the brain.
[Read More] 5 Penny Stocks To Buy For Under $2 Right Now
The company’s stock has been thriving on November 20th’s trading session. The biotech penny stock is up over 134.5% since this week’s lows whilst trading nearly 100 times its average trading volume. The price has increased from $0.2199 to nearly $0.50. This impressive move is thanks to a recent news break from Diffusion. The company recently presented its early findings from its Phase 3 glioblastoma study. These findings showed that inoperable glioblastoma patients had increased survival results.
“Although final conclusions will depend on the completion of the randomized portion of the trial, we believe that TSC helps to eradicate the low oxygen status of cancerous tumors, and it appears this may also result in a survival benefit compared with the current standard therapy,” explained Dr. John Gainer, Diffusion’s Chief Scientific Officer.
Like This Article? Check Out 3 Penny Stocks Making New 52-Week Highs; What’s Next?
